Calculate Risperdal lawsuit settlements. Male breast growth, diabetes, stroke claims.
Calculate SettlementJohnson & Johnson
Manufacturer
$2.2B
DOJ Settlement
$70M+
Jury Verdicts
Active
Litigation
Male breast growth requiring mastectomy
$400,000
projected value
Male breast growth, no surgery
$150,000
projected value
Type 2 diabetes development
$200,000
projected value
Risperdal lawsuits allege that Johnson & Johnson failed to warn that Risperdal causes gynecomastia (male breast growth) in boys and young men. J&J paid $2.2 billion to the DOJ in 2013 for illegal off-label marketing.
Individual verdicts have exceeded $70 million. Cases involving boys who developed breast tissue and required surgical removal have received the highest compensation.
Free calculator based on 2026 litigation data.
Start Free Calculator